US 10456404
Targeting cGMP-related phosphodiesterases to reduce cyst formation in cystic kidney disease, and related materials and methods
granted A61KA61K31/4985A61K31/506
Quick answer
US patent 10456404 (Targeting cGMP-related phosphodiesterases to reduce cyst formation in cystic kidney disease, and related materials and methods) held by United States Government as represented by the Department of Veterans Affairs expires Mon Oct 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- United States Government as represented by the Department of Veterans Affairs
- Grant date
- Tue Oct 29 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/4985, A61K31/506, A61K31/519, A61K31/53